The Meaning of Antipsychotic Medication to Patients With Schizophrenia

Seeman, Mary V.; Seeman, Neil

doi:10.1097/01.pra.0000419818.60505.95

Cited by 10 publications

(8 citation statements)

References 63 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Three authors (LAH, DRO, JCS) assessed each criterion and how it was met in each study. All authors were in agreement on final assessment of quality of articles included in the con- Articles included 49 qualitative research studies , six articles of instrument development and psychometrics [59][60][61][62][63][64], four meta-ethnographies [1,[65][66][67], five qualitative systematic literature reviews [68][69][70][71][72], one research note of interim data [73], and one personal case study [74]. Countries were represented from Australia, Brazil, Cambodia, Canada, Denmark, Germany, Iran, Japan, the Netherlands, New Zealand, Spain, Sweden, Switzerland, Thailand, the United Kingdom, the United States of America, and Wales.…”

Section: Data Sources and Sample Selectionmentioning

confidence: 99%

“…Moreover, they describe vulnerability as their perceived risk of taking a drug whose effectiveness is uncertain for them while living with the potential risk of significant side effects [15,47,51]. For patients who may need to use medications chronically, this long-term timeframe can elicit fear and a mix of emotions related to long-term use and consequences [17,21,62,72] as well as the fears related to the industrialized or synthetic nature of medications, as compared to natural products [17,42]. Additionally, patients are susceptible to the possibility of drug shortages and their high cost [25,42].…”

Section: Attributesmentioning

confidence: 99%

“…Not only do providers allow access to medications, but patients also need more information to feel comfortable about medication use [12,15,26,30,31,42,67]. Patients need a trusting relationship [27,36,39,40,66] with providers to engender a sense of security about their medications [11,44,52,72]. They depend on pharmacists and providers to give them accurate and understandable information about the effects and side effects of the drug and provide continuity and follow-up care to ensure safety and confidence [49,50,54,66].…”

Section: Attributesmentioning

confidence: 99%

See 2 more Smart Citations

The Medication Experience: A Concept Analysis

et al. 2020

View full text Add to dashboard Cite

This is a concept analysis of the medication experience with a focus on how it applies to the pharmaceutical care practice framework used by pharmacist practitioners. The medication experience is a vital component of pharmaceutical care practice and of patient-centered care. Although the experience of taking medication has been studied across disciplines for decades, a concept analysis of the medication experience is lacking. Rodgers’ evolutionary concept analysis method was utilized. Ovid Medline, CINAHL, PsycINFO, Sociological Abstracts and Google Scholar databases, references and hand searches were used to compile an international dataset of 66 papers published from 1982 to 2020. As a result of the available literature, the medication experience is defined as one of ambivalence and vulnerability in which the patient is actively engaged in an ongoing process or negotiation, which is pragmatic to the ways in which they live and experience life, contextualized and nuanced within the social construction of their individual realities. The concept of medication experience is an important addition to the scientific literature. The definition of medication experience from the perspective of the patient will help to better explain the concept for future research and theory development to move the discipline of pharmaceutical care practice forward.

show abstract

Section: Data Sources and Sample Selectionmentioning

confidence: 99%

Section: Attributesmentioning

confidence: 99%

Section: Attributesmentioning

confidence: 99%

See 1 more Smart Citation

The Medication Experience: A Concept Analysis

et al. 2020

View full text Add to dashboard Cite

show abstract

“…The key role of medication beliefs in adherence is illustrated by a recent qualitative synthesis of research on this topic in patients with schizophrenia, which highlighted beliefs about control, dependence and stigma [46]. Richardson et al [47] conducted a meta-analysis of the association between medication attitudes and adherence in patients with psychoses, finding 14 studies indicating a small to moderate association.…”

Section: Determinants Of Nonadherencementioning

confidence: 99%

Medication nonadherence and psychiatry

Chapman

Horne

2013

Current Opinion in Psychiatry

119

View full text Add to dashboard Cite

Purpose of reviewNonadherence to appropriately prescribed medication for psychiatric disorders prevents patients from realizing the full benefits of their treatment and negatively impacts on individuals, their families and the healthcare system. Understanding and reducing nonadherence is therefore a key challenge to quality care for patients with psychiatric disorders. This review highlights findings regarding the prevalence and consequence of nonadherence, barriers to adherence and new intervention methods from 2012 onwards.Recent findingsRecent research has highlighted that nonadherence is a global challenge for psychiatry and has linked nonadherence to poorer outcomes, including hospital admissions, suicide and mortality. Optimizing medication regimens can reduce nonadherence; however, often a complex interplay of factors affects individuals’ motivation and ability to follow their prescription. Psychiatrists can enable patients to develop an accurate model of their illness and treatment and facilitate adherence. However, nonadherence is often a hidden issue within consultations. Novel interventions using new technologies and tailoring techniques may have the potential to reduce nonadherence.SummaryNonadherence remains a significant challenge for patients with psychiatric disorders, physicians and healthcare systems. New developments demonstrate the importance of developing tailored interventions to enable patients to overcome perceptual and practical barriers to adherence.

show abstract

“…The rate at which the drug receptor dissociates from a receptor is determined by the “off” rate constant, k off (Table 1). The dissociation constant, K d , reflects the strength of the relationship between these “on” and “off” rates (Kapur & Seeman, 2001; Seeman & Seeman, 2002).…”

Section: Key Termsmentioning

confidence: 99%